| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.089 | 0.09 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.094 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.032 | 0.5 |